Form 4: Glaukos CFO Sells Shares, Gains Equity Awards

Glaukos Corporation's SVP & CFO, Alex R. Thurman, reported a sale of common stock and the acquisition of new equity awards, including restricted stock units and stock options, following the achievement of operational targets.

Summary

• Alex R. Thurman, SVP & Chief Financial Officer of Glaukos Corporation, sold 2,511 shares of common stock at a price of $106.46 per share on March 25, 2026.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Thurman on December 15, 2025.
• Mr. Thurman acquired 3,303 shares of common stock from a restricted stock unit (RSU) award previously granted on March 14, 2024, following the achievement of pre-determined operational targets as determined by the Compensation, Nominating and Governance Committee on March 25, 2026.
• 50% of these 3,303 RSU shares will vest and be delivered in March 2026, with the remaining 50% vesting and being delivered in December 2026.
• Mr. Thurman also acquired 8,228 stock options from an award granted on March 24, 2022, and 19,601 stock options from an award granted on March 22, 2023, both due to the achievement of pre-determined operational targets.
• 50% of the 8,228 stock options will vest and become exercisable in March 2026, and the remaining 50% in December 2026.
• A new stock option award of 20,515 shares was granted on March 25, 2026, with an exercise price of $109.60, vesting 25% on the first anniversary of the grant date and the remainder in equal monthly installments over the subsequent 36 months.
• Following these transactions, Mr. Thurman beneficially owns 45,270 shares of common stock and 85,854 derivative securities (stock options).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. While an insider sale occurred, it was pre-planned, and the significant acquisition of equity awards due to achieved operational targets suggests strong company performance.

Positives

• The acquisition of 3,303 shares of common stock and 27,829 stock options (8,228 + 19,601) resulted from the Issuer's achievement of pre-determined operational targets, indicating strong company performance.
• A new stock option award of 20,515 shares was granted to the SVP & CFO, aligning executive incentives with future company growth.

Negatives

• The SVP & CFO sold 2,511 shares of common stock, which could be perceived as a reduction in direct ownership, although it was part of a pre-arranged trading plan.

Future Outlook

The vesting schedules for the acquired restricted stock units and stock options extend into March and December 2026, and for the newly granted options, over a four-year period, indicating a long-term alignment of executive incentives with future company performance.

Industry Context

StockSavvy.ai notes that executive equity transactions, such as those reported in this Form 4, are common and often tied to pre-established compensation plans and performance metrics. The achievement of operational targets leading to the vesting and earning of awards suggests positive internal performance for Glaukos, which is a key indicator for investors.

Stakeholder Impact

• Shareholders: The pre-planned sale by a key executive is a routine event, but the achievement of operational targets for equity awards could be viewed positively as an indicator of company performance.
• Employees: The performance-based awards to a senior executive may reinforce a culture of performance and incentivize other employees.

Next Steps

• 50% of the 3,303 RSU shares will vest and be delivered in March 2026.
• The remaining 50% of the 3,303 RSU shares will vest and be delivered in December 2026.
• 50% of the 8,228 stock options will vest and become exercisable in March 2026.
• The remaining 50% of the 8,228 stock options will vest and become exercisable in December 2026.
• The 20,515 new stock options will vest 25% on the first anniversary of the grant date (March 25, 2027) and the remainder in equal monthly installments for 36 months thereafter, vesting in full on the four-year anniversary of the grant date.

Key Dates

Recommendation

The filing details routine insider transactions, including a pre-planned sale and performance-based equity awards. While the sale by a CFO might raise minor concerns, the underlying reason for the equity awards (achievement of operational targets) suggests positive internal performance. These transactions are generally expected and do not present a strong catalyst for a 'buy' or 'sell' recommendation, thus a 'hold' is appropriate.

Keywords

Glaukos, GKOS, Form 4, Insider Transaction, Executive Compensation, Stock Options, Restricted Stock Units, Alex R. Thurman, CFO